Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Challenges to decision-making processes in the national HTA agency in Brazil: operational procedures, evidence use and recommendations (2018)

  • Authors:
  • USP affiliated authors: NOVAES, HILLEGONDA MARIA DUTILH - FM ; SOÁREZ, PATRÍCIA COELHO DE - FM
  • USP Schools: FM; FM
  • DOI: 10.1186/s12961-018-0319-8
  • Subjects: TECNOLOGIAS DA SAÚDE; TOMADA DE DECISÃO; MEDICINA BASEADA EM EVIDÊNCIAS; CUSTOS DOS CUIDADOS DE SAÚDE
  • Agências de fomento:
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.1186/s12961-018-0319-8 (Fonte: oaDOI API)
    • Este periódico é de acesso aberto
    • Este artigo é de acesso aberto
    • URL de acesso aberto
    • Cor do Acesso Aberto: gold
    • Licença: cc-by

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      YUBA, Tania Yuka; NOVAES, Hillegonda Maria Dutilh; SOAREZ, Patricia Coelho de. Challenges to decision-making processes in the national HTA agency in Brazil: operational procedures, evidence use and recommendations. Health research policy and systems, London, v. 16, 2018. Disponível em: < http://dx.doi.org/10.1186/s12961-018-0319-8 > DOI: 10.1186/s12961-018-0319-8.
    • APA

      Yuba, T. Y., Novaes, H. M. D., & Soarez, P. C. de. (2018). Challenges to decision-making processes in the national HTA agency in Brazil: operational procedures, evidence use and recommendations. Health research policy and systems, 16. doi:10.1186/s12961-018-0319-8
    • NLM

      Yuba TY, Novaes HMD, Soarez PC de. Challenges to decision-making processes in the national HTA agency in Brazil: operational procedures, evidence use and recommendations [Internet]. Health research policy and systems. 2018 ; 16Available from: http://dx.doi.org/10.1186/s12961-018-0319-8
    • Vancouver

      Yuba TY, Novaes HMD, Soarez PC de. Challenges to decision-making processes in the national HTA agency in Brazil: operational procedures, evidence use and recommendations [Internet]. Health research policy and systems. 2018 ; 16Available from: http://dx.doi.org/10.1186/s12961-018-0319-8

    Referências citadas na obra
    Novaes H, De Soarez P. Avaliação de tecnologias em saúde: técnicas, práticas e políticas. In: Costa L, Bahia L, Gadelha C, editors. Saúde, Desenvolvimento e Inovação. Rio de Janeiro: Fiocruz; 2015. p. 327–58.
    Denis JL, Lehoux P, Champagne FA. Knowledge utilization perspective on fine-tuning dissemination and contextualizing knowledge. In: Lumieux-Charles L, Champagne F, editors. Using Knowledge and Evidence in Health Care. Toronto. Canada: University of Toronto Press; 2008. p. 18–40.
    Gibbons M, Limoges C, Nowotny H, Schwartzman S, Scott P, Trow M. The New Production of Knowledge: The Dynamics of Science and Research in Contemporary Societies. London: Sage; 1994.
    Ottoson J. Knowledge-for-action theories in evaluation: Knowledge utilization, diffusion, implementation, transfer, and translation. In: Ottoson JM, Hawe P, editors. Knowledge Utilization, Diffusion, Implementation, Transfer, and Translation: Implications for Evaluation New Directions for Evaluation; 2009. p. 7–20.
    Gerhardus A, Dorendorf E, Rottingen JA, Santamera AS. What are the effects of HTA reports on the health system? Evidence from the research literature. In: Velasco-Garrido M, Kristensen F, Nielsen C, Busse R, editors. Health Technology Assessment and Health Policy-Making in Europe: Current Status, Challenges and Potential. Brussels: WHO on behalf of the European Observatory on Health System and Policies; 2008.
    Novaes HM, Soárez PC. Health technology assessment (HTA) organizations: dimensions of the institutional and political framework. Cad Saude Publica. 2016;32(Suppl 2):e00022315.
    Brasil. Ministério da Saúde. Lei n° 12.401, de 28 de abril de 2011. Altera a Lei n° 8.080, de 19 de setembro de 1990 para dispor sobre a assistência terapêutica e a incorporação de tecnologia em saúde no âmbito do Sistema Único de Saúde. Brasília: Ministério da Saúde; 2011.
    Brasil. Ministério da Saúde. Decreto n° 7.646, de 21 de dezembro de 2011. Regulamenta a Lei n° 12.401, de 28 de abril de 2011 e Dispõe sobre a Comissão Nacional de Incorporação de Tecnologias no Sistema Único de Saúde e sobre o processo administrativo para incorporação, exclusão e alteração de tecnologias em saúde pelo Sistema Único de Saúde - SUS. Brasília: Ministério da Saúde; 2011.
    Raftery J, Powell J. Health technology assessment in the UK. Lancet. 2013;382:1278–85.
    Wilsdon T, Fiz E, Haderi A. A comparative analysis of the role and impact of Health Technology Assessment: 2013 CRA Project No D19197–00. Washington: CRA. Charles River Associates; 2014. p. 132.
    Silva HP, Petramale CA, Elias FT. Advances and challenges to the Brazilian policy of health technology management. Rev Saude Publica. 2012;46(Suppl 1):83–90.
    Merlin T, Tamblyn D, Ellery B, INAHTA Quality Assurance Group. What’s in a name? Developing definitions for common health technology assessment product types of the International Network of Agencies for Health Technology Assessment (INAHTA). Int J Technol Assess Health Care. 2014;30(4):430–7.
    Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, GW T. Methods for the Economic Evaluation of Health Care Programmes. London: Oxford; 2015. p. 464.
    Banco Central do Brasil. Calculadora do cidadão. Correção de valores. Índices de preços. https://www3.bcb.gov.br/CALCIDADAO/publico/exibirFormCorrecaoValores.do? .
    Nunes LMN, Fonteles MMF, Passos ACB, PSD A. Evaluation of demands of inclusion, exclusion and alteration of Technologies in the Brazilian Health System submitted to the National Committee on Technology Incorporation. Braz J Pharm Sci. 2017;53:e16073.
    Caetano R, Silva RMD, Pedro É, Oliveira IAG, Biz AN, Santana P. Incorporation of new medicines by the National Commission for Incorporation of Technologies, 2012 to June 2016. Cien Saude Colet. 2017;22:2513–25.
    Griffiths UK, Legood R, Pitt C. Comparison of economic evaluation methods across low-income, middle-income and high-income countries: what are the differences and why? Health Econ. 2016;25(Suppl 1):29–41.
    Pitt C, Vassall A, Teerawattananon Y, Griffiths UK, Guinness L, Walker D, Foster N, Hanson K. Foreword: Health economic evaluations in low- and middle-income countries: methodological issues and challenges for priority setting. Health Econ. 2016;25(Suppl 1):1–5.
    Soarez PC, Novaes HMD. Cost-effectiveness thresholds and the Brazilian Unified National Health System. Cad Saude Publica. 2017;33:e00040717.
    Decimoni TC, Leandro R, Rozman LM, Craig D, Iglesias CP, Novaes HMD, de Soárez PC. Systematic review of health economic evaluation studies developed in Brazil from 1980 to 2013. Front Public Health. 2018;6:52.
    Oliver K, Lorenc T, Innvær S. New directions in evidence-based policy research: a critical analysis of the literature. Health Res Policy Syst. 2014;12:34.
    Cairney P, Oliver K. Evidence-based policymaking is not like evidence-based medicine, so how far should you go to bridge the divide between evidence and policy? Health Res Policy Syst. 2017;15:35.
    Hupe P. And the rest is implementation.' Comparing approaches to what happens in policy processes beyond Great Expectations. Public Policy Admin. 2016;31:103–21.
    Liverani M, Hawkins B, Parkhurst JO. Political and institutional influences on the use of evidence in public health policy. A systematic review. PLoS One. 2013;8:e77404.
    Parkhurst J. The Politics of Evidence: From Evidence-Based Policy to the Good Governance of Evidence. Abingdon, Oxon: Routledge; 2017.